Loading peptide…
PeptideChat is for educational and research purposes only. Nothing on this site constitutes medical advice. Peptides are sold as research chemicals only and are not intended for human use. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. PeptideChat is an independent educational resource — not a pharmacy, compounding, or 503A/503B outsourcing facility — and does not sell products or provide medical advice.
Also known as: Prostamax
Prostamax is a synthetic peptide bioregulator studied in Russian research for supporting prostate tissue function and urinary health in aging males. It belongs to the short-peptide bioregulator family popularized by Khavinson.
Sign in to rate this peptide.
Prostamax is a short peptide proposed to act as a tissue-specific bioregulator that influences gene expression in prostate epithelial and stromal cells. Preclinical work suggests it modulates proliferation and secretory function, supports normalization of prostate tissue architecture, and may reduce inflammatory and oxidative markers. It is conceptually related to the natural prostate bioregulator Prostatic peptide (Prostatilen/Vitaprost). Evidence is based largely on Russian preclinical and limited clinical observation rather than rigorous controlled trials.